CONSORTIUM CHAIRS

Joel Freundlich

Associate Professor

Rutgers University New Jersey Medical School

Thomas Richardson

President

Institute for Life Science Entrepreneurship

WORKING GROUPS

TRANSLATIONAL SCIENCE

Joel Freundlich

Group Co-Lead; Associate Professor of Medicinal Chemistry at Rutgers University

Steven Projan

Group Co-Lead; Principal

Beat the Reaper, LLC

EDDY ARNOLD

Distinguished Professor of Chemistry and Chemical Biology at Rutgers University

KEITH BOSTIAN

CEO of ILSE; Dean, College of Science, Technology and Mathematics at Kean University

DAVID Perlin

CSO, Center for Discovery and Innovation

NANCY CONNELL

Senior Scholar, Professor, Health Security at Johns Hopkins

LINDA SAIF

Distinguished University Professor, Veterinary Preventive Medicine at Ohio State

AARON SCHMIDT

Assistant Professor, Microbiology at Harvard Medical School

PRISCILLA YANG

Associate Professor, Microbiology and Immunobiology at Harvard Medical School

Bryan Bryson

Assistant Professor of Biological Engineering

Esther and Harold E. Edgerton Career Development Assistant Professor

EDUCATION AND OUTREACH

Brad

Pendley

Group Co-Lead; Research Professor of Biomedical Engineering

University of Memphis​

Jeffrey H.

Toney

Group Co-Lead; Provost and Vice President for Research and Faculty at Kean University, Visiting Professor, Dept. of Linguistics and Philosophy at MIT, Visiting Scholar, Dept. of History of Science at Harvard University

ELIZABETH ARMSTRONG

Associate Professor, Sociology and Public Affairs at Princeton

Laura

Kahn

Research Health Policy Scholar, Science and Global Security

Princeton University

Dmitris Metaxas

Distinguished Professor, Computer Science

Rutgers University

Brad Pendley

Group Co-Lead; Research Professor of Biomedical Engineering

University of Memphis​

Paul Savage

CEO

HealthCare Intelligence

Patrick Smith

Senior Vice President, Integrated Drug Development

Certara Strategic Consulting

​

CONSULTANTS

WILLIAM HANLON

President of Clinical Therapeutic & Regulatory Services at Covance Drug Development

REBECCA PERKINS

Chair, Public Policy Working Group